Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 21, 2026.

Milk kefir: composition, microbial cultures, biological activities, and related products

Maria R. Prado, Lina Marcela Blandón, Luciana P. S. Vandenberghe and 4 more

Frontiers in Microbiology · 2015 · Review

doi:10.3389/fmicb.2015.01177

Abstract

In recent years, there has been a strong focus on beneficial foods with probiotic microorganisms and functional organic substances. In this context, there is an increasing interest in the commercial use of kefir, since it can be marketed as a natural beverage that has health promoting bacteria. There are numerous commercially available kefir based-products. Kefir may act as a matrix in the effective delivery of probiotic microorganisms in different types of products. Also, the presence of kefir's exopolysaccharides, known as kefiran, which has biological activity, certainly adds value to products. Kefiran can also be used separately in other food products and as a coating film for various food and pharmaceutical products. This article aims to update the information about kefir and its microbiological composition, biological activity of the kefir's microflora and the importance of kefiran as a beneficial health substance.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 21, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Kefir is an acidic-alcoholic fermented milk product with little acidic taste and creamy consistency that was originated in the Balkans, in Eastern Europe, and in the Caucasus. Kefir can be produced by fermenting milk with commercial freeze-dried kefir starter cultures, traditional kefir grains, and the product that remains after the removal of kefir grains. Kefir grains are a kind of yogurt starter, which are white to yellow – white, gelatinous, and variable in size (varying from 0.3–3.5 cm in diameter) and are composed by a microbial symbiotic mixture of lactic acid bacteria (108 CFU/g), yeast (106–107 CFU/g), and acetic acid bacteria (105CFU/g) that stick to a polysaccharide matrix. After successive fermentations, kefir grains can break up to new generation grains, which have the same characteristics as the old ones.

Commercial kefir is produced by two methods: The “Russian method” and the pure cultures. In the “Russian method” kefir is produced on a larger scale, using a series fermentation process, beginning with the fermentation of the grains and using the percolate. The other method employs pure cultures isolated from kefir grains or commercial cultures. Also, the industrial or commercial process uses direct-to-vat inoculation (DVI) or direct-to-vat set (DVS) kefir starter cultures. In addition, Bifidobacterium sp., Lactobacillus sp. and probiotic yeast (Saccharomyces boulardii) may be used as adjunct cultures when blended with kefir grains or kefir DVI cultures. On the other hand, whey may be a practical base for kefir culture production, and fermented whey has shown to be a suitable cryoprotective medium during freeze-drying. The freeze-dried culture retains a high survival rate and shows good metabolic activity and fermentation efficiency, indicating a good potential for its use as a value-added starter culture in dairy technology. All of these studies have shown promising perspectives for the application of kefir grains in whey valorization strategies.

Traditionally, kefir is manufactured using cow, ewe, goat, or buffalo milk. However, in some countries, animal milk is scarce, expensive, or minimally consumed due to dietary constraints, preferences, or religious customs. Therefore, there have been many attempts to produce kefir from a variety of food sources such as soy milk. Historically, kefir has been linked with health, for example, in Soviet countries, kefir has been recommended for consumption by healthy people to restrain the risk of some diseases. The consumption of this fermented milk has been related to a variety of health benefits not only linked to its microflora, but also due to the presence of some metabolic products as organic acids. In addition, kefir cultures have the ability to assimilate cholesterol in milk. On the other hand, there is a growing commercial interest in using kefir as a suitable food matrix for supplementation with health-promoting bacteria. Kefir may not only be a natural probiotic beverage, but also acts as an effective matrix for the delivery of probiotic microorganisms.

In kefir grains the main polysaccharide is kefiran, which is a heteropolysaccharide composed by equal proportions of glucose and galactose and is mainly produced by Lactobacillus kefiranofaciens. It has been demonstrated that kefiran improves the viscosity and viscoelastic properties of acid milk gels, and is able to form gels that have interesting viscoelastic properties at low temperatures, because of that, kefiran can also be used as an additive in fermented products. Besides, kefiran can enhance the rheological properties of chemically acidified skim milk gels increasing their apparent viscosity.

Compared with other polysaccharides, kefiran has outstanding advantages such as antitumor, antifungal, antibacterial properties immunomodulation or epithelium protection, anti-inflammatory, healing, and antioxidant activity.

This review presents the most recent advances about kefir and kefiran, their production and microbial cultures involved, biological activities and potential applications in health and food industries.

Microbial Composition of Kefir Grains and Kefir

Kefir grains have a complex composition of microbial species such as the predominance of lactic acid bacteria, acetic bacteria, yeasts, and fungi. This microbial species are classified into four groups: homofermentative and heterofermentative lactic acid bacteria and lactose and non-lactose assimilating yeast. In that way, Lactobacillus paracasei ssp. paracasei, Lactobacillus acidophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus plantarum, and L. kefiranofaciens are predominant species. However, these species represent only 20% of the Lactobacillus in the final fermented beverage, with the remainder consisting of Lactobacillus kefiri (80%;; ). Acetobacter aceti and A. rasens have also been isolated, such as the fungus Geotrichum candidum. More than 23 different yeast species have been isolated from kefir grains and from fermented beverages of different origins. However, the predominant species are Saccharomyces cerevisiae, S. unisporus, Candida kefyr, and Kluyveromyces marxianus ssp. marxianus (;;; Table 1).

The microbial composition may vary according to kefir origin, the substrate used in the fermentation process and the culture maintenance methods. Tibetan kefir, which is used in China, is composed of Lactobacillus, Lactococcus, and yeast. Additionally, acetic acid bacteria have been identified in Tibetan kefir, depending on the region in China from where it was obtained, additionally, Tibetan kefir composition differs from that of Russian kefir, Irish kefir, Taiwan kefir, Turkey fermented beverage with kefir; however, it is known that this microbial diversity is responsible for the physicochemical features and biological activities of each kefir.

examined a section of a whole kefir grain and found in the outer layer of the grain, lactococci, and yeasts, and, in the inner layer of the grain, the quantity of lactobacilli were much higher and more yeasts cells were found. There are little information about the mechanism of grain formation, so the same authors, proposed a hypothesis to explain that. “Initially, Lactobacillus kefiranofaciens and Saccharomyces turicensis start to auto-aggregate and co-aggregated to small granules.” The aggregation is enhanced when the pH drops. The biofilm producers, Lactobacillus kefiri, Kluyveromyces marxianus HY1, and Pichia fermentans HY3 then adhere to the surface of these small granules due to their cell surface properties and their strong aggregation ability, which gives rise to thin biofilms. After biofilm formation, the kefir yeasts and Lactobacillus continue to co-aggregated with the granule strains and associate with the granule biofilm to become a three dimensional microcolony. As the cell density due to the growth of kefir yeasts and Lactobacillus increases, cells and milk components that are present in the liquid phase accumulate on the granule surface and the kefir grains are formed. There is a symbiotic relation between the microorganisms present in kefir grains, wherein the bacteria and yeast survive and share their bioproducts as power sources and microbial growth factors. This microorganism association is responsible for lactic and alcoholic fermentation.

After receiving its actual/present denomination, some of the microorganisms isolated and identified in kefir cultures were classified using the product name, as in Lactobacillus kefiri, L. kefiranofaciens, L. kefirgranum, Lactobacillus parakefir, and Candida kefyr. Table 1 demonstrates the microbial composition, which has been isolated from kefir and kefir grains of different origins.

Biological Activity of Kefir

Due to its composition, kefir is mainly considered a probiotic resource. “Probiotics are microbial cell preparations or components of microbial cells with a beneficial effect on the health of the host”. Some studies suggest that probiotic bacteria in kefir consumers’ gut are abundant and are correlated with health improvement; in that way, it had been demonstrated that the cell-free fraction of kefir enhances the ability to digest lactose relieving symptoms.

Another reason for the increased interest in probiotic strains from kefir is its capacity to lower cholesterol levels. There are different ways in which bacteria can alter serum cholesterol: (i) through the binding to and absorption into the cell before it can be absorbed into the body; (ii) producing free and deconjugating bile acids; (iii) inhibiting the enzyme HMG-CoA reductase.

The microorganisms in the kefir grains produce lactic acid, antibiotics and bactericides, which inhibit the development of degrading and pathogenic microorganisms in kefir milk. Kefir acts against the pathogenic bacteria Salmonella, Helicobacter, Shigella, Staphylococcus, Escherichia coli, Enterobacter aerogenes, Proteus vulgaris, Bacillus subtilis, Micrococcus luteus, Listeria monocytogenes, Streptococcus pyrogenes,, Streptococcus faecalis KR6, Fusarium graminearum CZ1, and the fungus Candida albicans. On the other hand, it has been demonstrated that a mixture of kefir isolated bacteria and yeast is able to prevent diarrhea and enterocolitis triggered by Clostridium difficile. Besides, kefir showed good efficacy in inhibiting spore formation and aflatoxin B1 produced by the fungus Aspergillus flavus, which is a toxic compound formed either in the field or during food storage. Therefore, kefir appears as a promising safe alternative natural food preservative offering protection against intoxication with aflatoxin B1.

It had been proved that many species of lactobacilli present in kefir have S-layer proteins. Surface layers (S-layers) can be aligned in unit cells on the outermost surface of many prokaryotic microorganisms. It has been demonstrated that these S-layer proteins can apply a protective action inhibiting the grown of Salmonella enterica serovar Enteritidis in Caco-2 cells, and also have the ability to antagonize the effects of toxins from Clostridium difficile on eukaryotic/eukaryotic cells in vitro.

However, there are other important bioactivities that have been tested with kefir grains, the cell-free fraction of kefir or acid lactic bacteria isolated from kefir, such as antitumoral, anti-inflammatory, antimicrobial immunoregulatory, antiallergenic, wound healing, antidiabetic antimutagenic, and antigenotoxic. In that way, it had been demonstrated that kefir cell-free fraction has antiproliferative effects on human gastric cancer SGC7901 cells, colon adenocarcinoma cells, HuT–102 malignant T lymphocytes, sarcoma 180 in mice, Lewis lung carcinoma and human mammary cancer, and reduce oxidative stress. Another study has shown that suspensions after 24 h fermentation and mechanically disintegrated kefir grains cause a significant inhibition of granuloma tissue formation and a 43% inhibition of the inflammatory process.

Nevertheless, there are other important studies performed with some microorganisms isolated from different types of kefir. Some microorganisms with their biological activities and origin are shown in Table 2.

Kefiran, A Potential Exopolysaccharide

The increased search for natural polysaccharides has been very significant due to their use in the food, pharmaceutical, and cosmetic industries as additives, bio-absorbents, metal removal agents, bioflocculants, and medicine delivery agents, among other functions. Many microorganisms, such as bacteria, fungi, and weeds, have the capacity/ability to synthesize and excrete extracellular polysaccharides, and these polysaccharides can be either soluble or insoluble.

The polysaccharides that are commonly used as food additives are xanthan, dextran, gellan, and alginates, while the exopolysaccharides (EPSs) produced by lactic acid bacteria show good physicochemical characteristics for their use as food additives. In addition to these characteristics, EPSs are obtained from microorganisms classified as GRAS (generally recognized as safe), such as lactic acid bacteria.

Many reports have demonstrated that the quantity and properties of EPSs depend on the microorganisms used in the fermentation process and on the fermentation conditions and the composition of the culture media. EPSs have physicochemical and rheological properties that make them suitable as additives, which can be used as stabilizers, emulsifiers, gelling agents, and viscosity improvers. Additionally, EPSs possess biological properties suggesting their use as antioxidants, antitumor agents, antimicrobial agents, and immunomodulators, among other roles.

The EPS kefiran is produced by Lactobacillus kefiranofaciens from kefir grains, which are composed of proteins, polysaccharides, and a complex symbiotic microbial mixture. These microorganisms grow in kefiran, which is a polysaccharide matrix consisting of glucose and galactose. Despite good kefiran production by L. kefiranofaciens alone, it has been observed that the addition of Saccharomyces sp. to the culture improves the net quantity of kefiran, illustrating the importance of the symbiosis between the bacteria and yeast that are present in kefir.

Lactic acid bacteria can synthesize homopolysaccharides or heteropolysaccharides. The synthesized homopolysaccharides are glucans or fructans, which are composed of only one type of monosaccharide (glucose or fructose, respectively;; ), whereas the heteropolysaccharides contain different types of monosaccharides in different proportions (mainly glucose, galactose, and rhamnose),.

Similarly to lactic acid bacteria, Lactobacillus sp. also produces glucan and fructan. The homopolysaccharides show a much higher performance compared with heteropolysaccharide production.

The heteropolysaccharides excreted by Lactobacillus delbrueckii, Lactobacillus bulgaricus, Lactobacillus rhamnosus, and Lactobacillus helveticus contain galactose, glucose, and rhamnose as the main monosaccharides, with other monosaccharides being present in smaller concentrations. They are also highly branched with different types of linkages, and their denominations are complex and generally dependent on the main monosaccharide.

Lactobacillus plantarum isolated from Tibetan kefir excretes EPS classified as heteropolysaccharides composed of galactose, glucose, and mannose. This EPS has the capacity/ability to reduce blood cholesterol and form a biofilm shape.

Kefiran is an EPS classified as a heteropolysaccharide comprising glucose and galactose in high concentrations, and it is classified as a water-soluble glucogalactan, which makes it suitable to be used as an additive. Kefiran has excellent rheological properties and can significantly improve the viscosity of lacteous products by favoring and maintaining gel properties and avoiding the loss of water during storage. With respect to the biological activity of kefiran, several studies have demonstrated that this EPS can be used as a nutraceutical, as described in Table 3.

The first study about kefiran structure was published by, who proposed a structure composed of two units: kefiran (polysaccharide) and kefirose (pentasaccharide). Then, some authors analyzed the polysaccharide structure with current techniques such chromatography and infrared spectroscopy and nuclear magnetic resonance (NMR; ). The kefiran structure, according to them, is shown in Figure 1.

Kefir-Based Products

Nowadays, the interest in developing functional foods is increasing because people want to improve their health and prevent diseases. Keeping in mind that kefir is a beverage with high probiotic activity, among other bioactivities, new companies are emerging around the world. One of the biggest kefir companies known is Lifeway, which started in 1986; their products can be obtained in the United States, Canada, and Great Britain, all of them based in kefir beverages, frozen, and cheese.

Other companies are Evolve Kefir with its principal product, a smoothie; Wallaby Yogurt Company with Low Fat Kefir; and CocoKefir LLC, which provides drinks/beverages based mainly on coconut water cultured with a comprehensive blend of probiotics. Table 4 summarizes the products provided these companies with some general information about each one.

Conclusion

Kefir, the traditional beverage, is now recognized as a potential source of probiotics and molecules with highly interesting healthy properties. The careful and detailed characterization of kefir composition has helped the scientific community to find new possibilities for its application. Kefiran, the EPS of kefir, has very important physicochemical and rheological properties. Besides, its biological properties suggest its use as antioxidant, antitumor agent, antimicrobial agent, and immunomodulator, among other roles. Research is constantly being conducted to consolidate kefir and kefiran properties for the development of new important products to preserve consumer’s health.

Acknowledgment

Authors want to thank CNPq and CAPES for the financial support.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 98

  1. 1.

    Ahmed Z. Wang Y. Ahmad A. Khan S. T. Nisa M. Ahmad H. (2013 ). Kefir and health: a contemporary perspective. Crit. Rev. Food Sci. Nutr. 53 422–434.

    Not in our library10.1080/10408398.2010.540360

  2. 2.

    Altay F. Karbancıoglu-Güler F. Daskaya-Dikmen C. Heperkan D. (2013 ). A review on traditional Turkish fermented non-alcoholic beverages: microbiota, fermentation process and quality characteristics. Int. J. Food Microbiol. 167 44–56.

    Not in our library10.1016/j.ijfoodmicro.2013.06.016

  3. 3.

    Anselmo R. J. Viora S. S. Ojeda P. A. Lausada L. I. (2010 ). Efecto antagónico del kefir sobre endosporas y células vegetativas de Bacillus cereus y Clostridium perfringens. (Spanish) Antagonistic effect of the kefir on endospores and vegetative cells of Bacillus cereus and Clostridium perfringens. Inf. Tecnol. 21 131–138.

    Not in our library

  4. 4.

    Badel S. Bernardi T. Michaud P. (2011 ). New perspective for Lactobacilli exopolysaccharides. Biotecnol. Adv. 29 54–66.

    Not in our library10.1016/j.biotechadv.2010.08.011

  5. 5.

    Bensmira M. Nsabimana C. Jiang B. (2010 ). Effects of fermentation conditions and homogenization pressure on the rheological properties of Kefir. Food Sci. Technol. 43 1180–1184.

    Not in our library

  6. 6.

    Bolla P. A. Carasi P. Bolla Mde L. De Antoni G. L. Serradell Mde L. (2013 ). Protective effect of a mixture of kefir-isolated lactic acid bacteria and yeasts in a hamster model of Clostridium difficile infection. Anaerobe 21 28–33.

    Not in our library10.1016/j.anaerobe.2013.03.010

  7. 7.

    Botelho P. S. Maciel M. I. Bueno L. A. Marques Mde F. Marques D. N. Sarmento Silva T. M. (2014 ). Characterization of a new exopolysaccharide obtained from of fermented kefir grains in soymilk. Carbohydr. Polym. 107 1–6.

    Not in our library10.1016/j.carbpol.2014.02.036

  8. 8.

    Carasi P. Trejo F. M. Pérez P. F. De Antoni G. L. Serradell Mde L. (2012 ). Surface proteins from Lactobacillus kefir antagonize in vitro cytotoxic effect of Clostridium difficile toxins. Anaerobe 18 135–142.

    Not in our library10.1016/j.anaerobe.2011.11.002

  9. 9.

    Cevikbas A. Yemni E. Ezzedenn F. W. Yardimici T. Cevikbas U. Stohs S. J. (1994 ). Antitumoural, antibacterial and antifungal activities of kefir and kefir grain. Phytother. Res. 8 78–82.

    Not in our library10.1002/ptr.2650080205

  10. 10.

    Cheirsilp B. Radchabut S. (2011 ). Use of whey lactose from dairy industry for economical kefiran production by Lactobacillus kefiranofaciens in mixed cultures with yeasts. N. Biotechnol. 28 574–580.

    Not in our library10.1016/j.nbt.2011.01.009

  11. 11.

    Cheirsilp B. Shimizu H. Shioya S. (2003 ). Enhanced kefiran production by mixed culture of Lactobacillus kefiranofaciens and Saccharomyces cerevisiae. J. Biotechnol. 100 43–53.

    Not in our library10.1016/s0168-1656(02)00228-6

  12. 12.

    Chen H. C. Wang S. Y. Chen M. J. (2008 ). Microbiological study of lactic acid bacteria in kefir grains by culture-dependent and culture-independent methods. Food Microbiol. 25 492–501.

    Not in our library10.1016/j.fm.2008.01.003

  13. 13.

    Chen Y. P. Hsiao P. J. Hong W. S. Dai T. Y. Chen M. J. (2012 ). Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vivo. J. Dairy Sci. 95 63–74.

    Not in our library10.3168/jds.2011-4696

  14. 14.

    Chen Z. Shi J. Yang X. Nan B. Liu Y. Wang Z. (2015 ). Chemical and physical characteristics and antioxidant activities of the exopolysaccharide produced by Tibetan kefir grains during milk fermentation. Int. Dairy J. 43 15–21.

    Not in our library10.1016/j.idairyj.2014.10.004

  15. 15.

    De Vuyst L. Degeest B. (1999 ). Heteropolysaccharides from lactic acid bacteria. FEMS Microbiol. Rev. 23 153–177.

    Not in our library10.1111/j.1574-6976.1999.tb00395.x

  16. 16.

    De Vuyst L. De Vin F. Kamerling J. P. (2001 ). Recent developments in the biosynthesis and applications of heteropolysaccharides from lactic acid bacteria. Int. Dairy J. 11 687–707.

    Not in our library10.1016/s0958-6946(01)00114-5

  17. 17.

    Diniz R. Garla L. Schneedorf J. Carvalho J. C. (2003 ). Study of anti-inflammatory activity of Tibetan mushroom, a symbiotic culture of bacteria and fungi encapsulated into a polysaccharide matrix. Pharmacol. Res. 47 49–52.

    Not in our library10.1016/s1043-6618(02)00240-2

  18. 18.

    Diosma G. Romanin D. E. Rey-Burusco M. F. Londero A. Garrote G. L. (2014 ). Yeasts from kefir grains: isolation, identification, and probiotic characterization. World J. Microbiol. Biotechnol. 30 43–53.

    Not in our library10.1007/s11274-013-1419-9

  19. 19.

    Dobson A. O’Sullivan O. Cotter P. D. Ross P. Hill C. (2011 ). High-throughput sequence-based analysis of the bacterial composition of kefir and an associated kefir grain. FEMS Microbiol. Lett. 320 56–62.

    Not in our library10.1111/j.1574-6968.2011.02290.x

  20. 20.

    Duarte J. Vinderola G. Ritz B. Perdigon G. Matar C. (2006 ). Immunomodulating capacity of commercial fish protein hydrolysate for diet supplementation. Immunobiology 211 341–350.

    Not in our library10.1016/j.imbio.2005.12.002

  21. 21.

    Farnworth E. R. (2005 ). Kefir – a complex probiotic. Food Sci. Technol. Bull. Funct. Foods 2 1–17.

    Not in our library10.1616/1476-2137.13938

  22. 22.

    Farnworth E. R. Mainville I. (2003 ). “Kefir: a fermented milk product,” in Handbook of Fermented Functional Foods, ed. Farnworth E. R. (Boca Raton, FL: CRC Press), 77–112.

    Not in our library

  23. 23.

    Fontán M. C. G. Martínez S. Franco I. Carballo J. (2006 ). Microbiological and chemical changes during the manufacture of Kefir made from cows’ milk, using a commercial starter culture. Int. Dairy J. 16 762–767.

    Not in our library10.1016/j.idairyj.2005.07.004

  24. 24.

    Gao J. Gu F. Abdella N. H. Ruan H. He G. (2012 ). Investigation on culturable microflora in Tibetan kefir grains from different areas of China. J. Food Sci. 77 425–433.

    Not in our library10.1111/j.1750-3841.2012.02805.x

  25. 25.

    Gao J. Gu F. He J. Xiao J. Chen Q. Ruan H. (2013a ). Metagenome analysis of bacterial diversity in Tibetan kefir grains. Eur. Food Res. Technol. 236 549–556.

    Not in our library10.1007/s00217-013-1912-2

  26. 26.

    Gao J. Gu F. Ruan H. Chen Q. He J. He G. (2013b ). Induction of apoptosis of gastric cancer cells SGC7901 in vitro by a cell-free fraction of Tibetan kefir. Int. Dairy J. 30 14–18.

    Not in our library10.1016/j.idairyj.2012.11.011

  27. 27.

    Garofalo C. Osimani A. Milanovič V. Aquilanti L. De Filippis F. Stellato G. (2015 ). Bacteria and yeast microbiota in milk kefir grains from different Italian regions. Food Microbiol. 49 123–133.

    Not in our library10.1016/j.fm.2015.01.017

  28. 28.

    Garrote G. L. Abraham A. G. De Antoni G. L. (2001 ). Chemical and microbiological characterisation of kefir grains. J. Dairy Res. 68 639–652.

    Not in our library10.1017/s0022029901005210

  29. 29.

    Garrote G. L. Abraham A. G. De Antoni G. L. (2010 ). “Microbial Interactions in Kefir: a Natural Probiotic Drink,” in Biotechnology of Lactic Acid Bacteria, eds Mozzi F. Raya R. R. Vignolo G. M. (Ames, IO: Wiley-Blackwell), 327–340.

    Not in our library

  30. 30.

    Ghasemlou M. Khodaiyan F. Jahanbin K. Mohammad S. Gharibzahedi T. Taheri S. (2012 ). Structural investigation and response surface optimisation for improvement of kefiran production yield from a low-cost culture medium. Food Chem. 133 383–389.

    Not in our library10.1016/j.foodchem.2012.01.046

  31. 31.

    Grishina A. Kulikova I. Alieva L. Dodson A. Rowland I. Jing J. (2011 ). Antigenotoxic effect of kefir and ayran supernatants on fecal water-induced DNA damage in human colon cells. Nutr. Cancer 63 73–79.

    Not in our library10.1080/01635581.2010.516873

  32. 32.

    Guzel-Seydim Z. B. Seydim A. C. Greene A. K. Ta T. (2006 ). Determination of antimutagenic properties of acetone extracted fermented milks and changes in their total fatty acid profiles including conjugated linoleic acids. Int. J. Dairy Technol. 59 209–215.

    Not in our library10.1111/j.1471-0307.2006.00265.x

  33. 33.

    Guzel-Seydim Z. Wyffels J. T. Seydim A. C. Greene A. K. (2005 ). Turkish kefir and kefir grains: microbial enumeration and electron microscopic observation. Int. J. Dairy Technol. 58 25–29.

    Not in our library10.1111/j.1471-0307.2005.00177.x

  34. 34.

    Hamet M. F. Londero A. Medrano M. Vercammen E. Van Hoorde K. Garrote G. L. (2013 ). Application of culture-dependent and culture-independent methods for the identification of Lactobacillus kefiranofaciens in microbial consortia present in kefir grains. Food Microbiol. 36 327–334.

    Not in our library10.1016/j.fm.2013.06.022

  35. 35.

    Hong W. S. Chen H. C. Chen Y. P. Chen M. J. (2009 ). Effects of kefir supernatant and lactic acid bacteria isolated from kefir grain on cytokine production by macrophage. Int. Dairy J. 19 244–251.

    Not in our library10.1016/j.idairyj.2008.10.010

  36. 36.

    Huseini H. F. Rahimzadeh G. Fazeli M. R. Mehrazma M. Salehi M. (2012 ). Evaluation of wound healing activities of kefir products. Burns 38 719–723.

    Not in our library10.1016/j.burns.2011.12.005

  37. 37.

    Ismaiel A. A. Ghaly M. F. El-Naggar A. K. (2011 ). Milk kefir: ultrastructure, antimicrobial activity and efficacy on aflatoxin b1 production by Aspergillus flavus. Curr. Microbiol. 62 1602–1609.

    Not in our library10.1007/s00284-011-9901-9

  38. 38.

    Jianzhong Z. Xiaoli L. Hanhu J. Mingsheng D. (2009 ). Analysis of the microflora in Tibetan kefir grains using denaturing gradient gel electrophoresis. Food Microbiol. 26 770–775.

    Not in our library10.1016/j.fm.2009.04.009

  39. 39.

    Kabak B. Dobson A. D. (2011 ). An introduction to the traditional fermented foods and beverages of Turkey. Crit. Rev. Food Sci. Nutr. 51 248–260.

    Not in our library10.1080/10408390903569640

  40. 40.

    Kesmen Z. Kacmaz N. (2011 ). Determination of lactic microflora of kefir grains and kefir beverage by using culture-dependent and culture-independent methods. J. Food Sci. 76 276–283.

    Not in our library10.1111/j.1750-3841.2011.02191.x

  41. 41.

    Khoury N. El-Hayek S. Tarras O. El-Sabban M. El-Sibai M. Rizk S. (2014 ). Kefir exhibits anti-proliferative and pro-apoptotic effects on colon adenocarcinoma cells with no significant effects on cell migration and invasion. Int. J. Oncol. 45 2117–2127.

    Not in our library10.3892/ijo.2014.2635

  42. 42.

    Kim Y. Kim J. U. Oh S. Kim Y. J. Kim M. Kim S. H. (2008 ). Technical optimization of culture conditions for the production of exopolysaccharide (EPS) by Lactobacillus rhamnosus ATCC 9595. Food Sci. Biotechnol. 17 587–593.

    Not in our library

  43. 43.

    Kok-Tas T. Ekinci F. Y. Guzel eSeydim Z. B. (2012 ). Identification of microbial flora in kefir grains produced in Turkey using PCR. Int. J. Dairy Technol. 65 126–131.

    Not in our library10.1111/j.1471-0307.2011.00733.x

  44. 44.

    Kooiman P. (1968 ). The chemical structure of kefiran, the water-soluble polysaccharide of the kefir grain. Carbohydr. Res. 7 220–221.

    Not in our library10.1016/s0008-6215(00)81138-6

  45. 45.

    Korsak N. Taminiau B. Leclercq M. Nezer C. Crevecoeur S. Ferauche C. (2015 ). Short communication: evaluation of the microbiota of kefir samples using metagenetic analysis targeting the 16S and 26S ribosomal DNA fragments. J. Dairy Sci. 98 3684–3689.

    Not in our library10.3168/jds.2014-9065

  46. 46.

    Kwon C. S. Park M. Y. Cho J. S. Choi S. T. Chang D. S. (2003 ). Identification of effective microorganisms from kefir fermented milk. Food Sci. Biotechnol. 12 476–479.

    Not in our library

  47. 47.

    Leite A. M. O. Mayoa B. Rachid C. T. Peixoto R. S. Silva J. T. Paschoalin V. M. (2012 ). Assessment of the microbial diversity of Brazilian kefir grains by PCR-DGGE and pyrosequencing analysis. Food Microbiol. 31 215–221.

    Not in our library10.1016/j.fm.2012.03.011

  48. 48.

    Leite A. M. O. Miguel M. A. Peixoto R. S. Rosado A. S. Silva J. T. Paschoalin V. M. (2013 ). Microbiological, technological and therapeutic properties of kefir: a natural probiotic beverage. Braz. J. Microbiol. 44 341–349.

    Not in our library10.1590/s1517-83822013000200001

  49. 49.

    Liu J. R. Wang S. Y. Lin Y. Y. Lin C. W. (2002 ). Antitumor activity of milk, kefir and soya milk kefir in tumor bearing mice. Nutr. Cancer 44 183–187.

    Not in our library10.1207/s15327914nc4402_10

  50. 50.

    Londero A. Hamet M. F. De Antoni G. L. Garrote G. L. Abraham A. G. (2012 ). Kefir grains as a starter for whey fermentation at different temperatures: chemical and microbiological characterisation. J. Dairy Res. 79 262–271.

    Not in our library10.1017/s0022029912000179

  51. 51.

    Lopitz F. O. Rementeria A. Elguezabal N. Garaizar J. (2006 ). Kefir: una comunidad simbiótica de bacterias y levaduras con propiedades saludables. Rev. Iberoam. Micol. 23 67–74.

    Not in our library10.1016/s1130-1406(06)70016-x

  52. 52.

    Maeda H. Zhu X. Suzuki S. Suzuki K. Kitamura S. (2004 ). Structural characterization and biological activities of an exopolysaccharide kefiran produced by Lactobacillus kefiranofaciens WT-2B(T). J. Agric. Food Chem. 52 5533–5538.

    Not in our library10.1021/jf049617g

  53. 53.

    Magalhães K. T. Pereira G. V. M. Campos C. R. Dragone G. Schwan R. F. (2011 ). Brazilian kefir: structure, microbial communities and chemical composition. Braz. J. Microbiol. 42 693–702.

    Not in our library10.1590/s1517-838220110002000034

  54. 54.

    McCue P. P. Shetty K. (2005 ). Phenolic antioxidant mobilization during yogurt production from soymilk using Kefir cultures. Process Biochem. 40 1791–1797.

    Not in our library10.1016/j.procbio.2004.06.067

  55. 55.

    Medrano M. Pérez P. F. Abraham A. G. (2008 ). Kefiran antagonizes cytopathic effects of Bacillus cereus extracellular factors. Int. J. Food Microbiol. 122 1–7.

    Not in our library10.1016/j.ijfoodmicro.2007.11.046

  56. 56.

    Miguel M. G. C. P. Cardoso P. G. Lago L. A. Schwan R. F. (2010 ). Diversity of bacteria present in milk kefir grains using culture-dependent and culture-independent methods. Food Res. Int. 43 1523–1528.

    Not in our library10.1016/j.foodres.2010.04.031

  57. 57.

    Mobili P. Serradell Mde L. A. Trejo S. A. Avilés Puigvert F. X. Abraham A. G. (2009 ). Heterogeneity of S-layer proteins from aggregating and non-aggregating Lactobacillus kefir strains. Antonie Van Leeuwenhoek 95 363–372.

    Not in our library10.1007/s10482-009-9322-y

  58. 58.

    Nalbantoglu U. Cakar A. Dogan H. Abaci N. Ustek D. Sayood K. (2014 ). Metagenomic analysis of the microbial community in kefir grains. Food Microbiol. 41 42–51.

    Not in our library10.1016/j.fm.2014.01.014

  59. 59.

    Oliveira A. M. L. Miguel M. A. L. Peixoto R. S. Rosado A. S. Silva J. T. Paschoalin V. M. F. (2013 ). Microbiological, technological and therapeutic properties of kefir: a natural probiotic beverage. Braz. J. Microbiol. 44 341–349.

    Not in our library10.1590/s1517-83822013000200001

  60. 60.

    Piermaria J. Bosch A. Pinotti A. Yantorno O. Garcia M. A. Abraham A. G. (2010 ). Kefiran films plasticized with sugars and polyols: water vapor barrier and mechanical properties in relation to their microstructure analyzed by ATR/FT-IR spectroscopy. Food Hydrocoll. 25 1261–1269.

    Not in our library10.1016/j.foodhyd.2010.11.024

  61. 61.

    Pogačić T. Sinko S. Zamberlin S. Samarzija D. (2013 ). Microbiota of kefir grains. Mljekarstvo 63 3–14.

    Not in our library

  62. 62.

    Powell J. E. Witthuhn R. C. Todorov S. D. Dicks L. M. T. (2007 ). Characterization of bacteriocin ST8KF produced by a kefir isolate Lactobacillus plantarum ST8KF. Int. Dairy J. 17 190–198.

    Not in our library10.1016/j.idairyj.2006.02.012

  63. 63.

    Punaro G. R. Maciel F. R. Rodrigues A. M. Rogero M. M. Bogsan C. S. B. Oliveira M. N. (2014 ). Kefir administration reduced progression of renal injury in STZ-diabetic rats by lowering oxidative stress. Nitric Oxide 37 53–60.

    Not in our library10.1016/j.niox.2013.12.012

  64. 64.

    Raja A. Gajalakshmi P. Raja M. M. M. Imran M. M. (2009 ). Effect of Lactobacillus laceis cremoris isolated from Kefir against food spoilage bacteria. Am. J. Food Technol. 4 201–209.

    Not in our library10.3923/ajft.2009.201.209

  65. 65.

    Rimada P. S. Abraham A. G. (2006 ). Effects of different fermentation parameters on quality characteristics of kefir. Int. Dairy J. 16 33–39.

    Not in our library10.3168/jds.2012-5753

  66. 66.

    Rizk S. Maalouf K. Baydoun E. (2009 ). The Antiproliferative effect of kefir cell-free fraction on HuT-102 malignant T lymphocytes. Clin. Lymphoma Myeloma 9 198–203.

    Not in our library10.3816/clm.2009.s.012

  67. 67.

    Rodrigues K. L. Caputo L. R. G. Carvalho J. C. T. Evangelista J. Schneedorf J. M. (2005a ). Antimicrobial and healing activity of kefir and kefiran extract. Int. J. Antimicrob. Agents 25 404–408.

    Not in our library10.1016/j.ijantimicag.2004.09.020

  68. 68.

    Rodrigues K. L. Carvalho J. C. T. Schneedorf J. M. (2005b ). Anti-inflammatory properties of kefir and its polysaccharide extract. Inflammopharmacology 13 485–492.

    Not in our library10.1163/156856005774649395

  69. 69.

    Ruas-Madiedo P. Hugenholtz J. Zoon P. (2002 ). An overview of the functionality of exopolysaccharides produced by lacti acid bacteria. Int. Dairy J. 12 163–171.

    Not in our library10.1016/s0958-6946(01)00160-1

  70. 70.

    Saija N. Welman A. Bennett R. (2010 ). Development of a dairy-based exopolysaccharide bioingredient. Int. Dairy J. 20 603–608.

    Not in our library10.1016/j.idairyj.2010.03.011

  71. 71.

    Saloff-Coste C. J. (1996 ). Kefir. Nutritional and health benefits of yoghurt and fermented milks. Dannone World Newsl. 11 1–7.

    Not in our library

  72. 72.

    Serafini F. Turroni P. Ruas-Madiedo G. A. Lugli C. Milani S. Duranti N. (2014 ). Kefir fermented milk and kefiran promote growth of Bifidobacterium bifidum PRL2010 and modulate its gene expression. Int. J. Food Microbiol. 178 50–59.

    Not in our library10.1016/j.ijfoodmicro.2014.02.024

  73. 73.

    Simova E. Beshkova D. Angelov A. Hristozova T. Frengova G. Spasov Z. (2002 ). Lactic acid bacteria and yeasts in kefir grains and kefir made from them. J. Ind. Microbiol. Biotechnol. 28 1–6.

    Not in our library10.1038/sj.jim.7000186

  74. 74.

    Soccol C. R. Prado M. R. M. Garcia L. M. B. Rodrigues C. Medeiros A. B. P. (2014 ). Current developments in probiotics. J. Microb. Biochem. Technol. 7 011–020.

    Not in our library10.4172/1948-5948.1000175

  75. 75.

    St-Onge M. P. Farnworth E. R. Savard T. Chabot D. Mafu A. Jones P. J. (2002 ). Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial. BMC Complement. Altern. Med. 2:1

    Not in our library10.1186/1472-6882-2-1

  76. 76.

    Suresh Kumar A. Mody K. Jha B. (2008 ). Bacterial exopolysaccharides – a perception. J. Basic Microbiol. 47 103–117.

    Not in our library10.1002/jobm.200610203

  77. 77.

    Van Hijum S. A. Kralj S. Ozimek L. K. Dijkhuizen L. Van Geel-Achutten I. G. (2006 ). Structural-function relationships of glucansucrases and fructan enzymes from lactic acid bacteria. Microbiol. J. Biol. Macromol. 70 157–176.

    Not in our library10.1128/mmbr.70.1.157-176.2006

  78. 78.

    Vinderola G. Perdigon G. Duarte J. Farnworth E. Matar C. (2006 ). Effects of the oral administration of the products derived from milk fermentation by kefir microflora on immune stimulation. J. Dairy Res. 73 472–479.

    Not in our library10.1017/s002202990600197x

  79. 79.

    Vujičič I. F. Vulić M. Könyves T. (1992 ). Assimilation of cholesterol in milk by kefir cultures. Biotechnol. Lett. 14 847–850.

    Not in our library10.1007/bf01029151

  80. 80.

    Wang S. Y. Chen K. N. Lo Y. M. Chiang M. L. Chen H. C. Liu J. R. (2012 ). Investigation of microorganisms involved in biosynthesis of the kefir grain. Food Microbiol. 32 274–285.

    Not in our library10.1016/j.fm.2012.07.001

  81. 81.

    Wang Y. Ahmed Z. Feng W. Li C. Song S. (2008 ). Physicochemical properties of exopolysaccharide produced by Lactobacillus kefiranofaciens ZW3 isolated from Tibet kefir. Int. J. Biol. Macromol. 43 283–288.

    Not in our library10.1016/j.ijbiomac.2008.06.011

  82. 82.

    Wang Y. P. Li C. Liu P. Zaheer A. Xiao P. Bai X. (2010 ). Physical characterization of exopolysaccharide produced by Lactobacillus plantarum KF5 isolated from Tibet Kefir. Carbohydr. Polym. 82 895–903.

    Not in our library10.1016/j.carbpol.2010.06.013

  83. 83.

    Wei-Sheng H. Yen-Po C. Ming-Ju C. (2010 ). The Antiallergic effect of kefir Lactobacilli. J. Food Sci. 75 244–253.

    Not in our library10.1111/j.1750-3841.2010.01787.x

  84. 84.

    Welman A. D. Maddox I. S. (2003 ). Exopolysaccharides from lactic acid bacteria: perspectives and challenges. Trends Biotechnol. 21 269–274.

    Not in our library10.1016/s0167-7799(03)00107-0

  85. 85.

    Witthuhn R. C. Schoeman T. Britz T. J. (2004 ). Isolation and characterisation of the microbial population of different South African kefir grains. Int. J. Dairy Technol. 57 33–37.

    Not in our library10.1111/j.1471-0307.2004.00126.x

  86. 86.

    Witthuhn R. C. Schoeman T. Britz T. J. (2005 ). Characterisation of the microbial population at different stages of kefir production and kefir grain mass cultivation. Int. Dairy J. 15 383–389.

    Not in our library10.1016/j.idairyj.2004.07.016

  87. 87.

    Wszolek M. Kupiec-Teahan B. Skov Gulard H. Tamime A. Y. (2006 ). “Production of kefir, koumiss and other related products,” in Fermented Milks, ed. Tamime A. Y. (Oxford: Blackwell Publishing), 174–216.

    Not in our library

  88. 88.

    Wyder M. T. Meile L. Teuber M. (1999 ). Description of Saccharomyces turicensis sp. nov., a new species from kefyr. Syst. Appl. Microbiol. 3 420–425.

    Not in our library10.1016/s0723-2020(99)80051-4

  89. 89.

    Yang X. J. Fan M. T. Shi J. L. Dang B. (2007 ). Isolation and identification of preponderant flora in Tibetan kefir. China Brewing 171 52–55.

    Not in our library

  90. 90.

    Yanping W. Nv X. Aodeng X. Zaheer A. Bin Z. Xiaojia B. (2009 ). Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Appl. Microbiol. Biotechnol. 84 341–347.

    Not in our library10.1007/s00253-009-2012-x

  91. 91.

    Ying H. Fei W. Xiaojun W. Yujie S. Longfei Y. Jinfeng W. (2013 ). Characterization of Lactobacillus plantarum Lp27 isolated from Tibetan kefir grains: a potential probiotic bacterium with cholesterol-lowering effects. J. Dairy Sci. 96 2816–2825.

    Not in our library10.3168/jds.2012-6371

  92. 92.

    Young-In K. Apostolidis E. Shetty K. (2006 ). Anti-diabetes functionality of kefir culture-mediated fermented soymilk supplemented with Rhodiola extracts. Food Biotechnol. 20 13–29.

    Not in our library10.1080/08905430500522055

  93. 93.

    Yüksekdag Z. N. Beyatli Y. Aslim B. (2004 ). Determination of some characteristics coccoid forms of lactic acid bacteria isolated from Turkish kefirs with natural probiotic. Food Sci. Technol. 37 663–667.

    Not in our library

  94. 94.

    Zajšek K. Goršek A. Kolar M. (2013 ). Cultivating conditions effects on kefiran production by the mixed culture of lactic acid bacteria imbedded within kefir grains. Food Chem. 139 970–977.

    Not in our library10.1016/j.foodchem.2012.11.142

  95. 95.

    Zajšek K. Kolar M. Goršek A. (2011 ). Characterisation of the exopolysaccharide kefiran produced by lactic acid bacteria entrapped within natural kefir grains. Int. J. Dairy Technol. 64 544–548.

    Not in our library10.1111/j.1471-0307.2011.00704.x

  96. 96.

    Zanirati D. F. Abatemarco M. Cicco Sandesb S. H. Nicolia J. R. Nunes A. C. Neumanna E. (2015 ). Selection of lactic acid bacteria from Brazilian kefir grains for potential use as starter or probiotic cultures. Anarobe 32 70–76.

    Not in our library10.1016/j.anaerobe.2014.12.007

  97. 97.

    Zhang B. Xu N. Xi A. D. Wang Y. P. (2009 ). Screening and identification of cholesterol-reducing KF5 strain. J. Tianjin Univ. Sci. Technol. 24 17–20.

    Not in our library

  98. 98.
    Probiotic properties of Lactobacillus strains isolated from Tibetan kefir grains. · 2013
    Not checked

Cited by papers we hold 8

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.